Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Currently, the analyst consensus on JD Health International, Inc. is a Strong Buy with an average price target of HK$72.11.
Based on JD Health International, Inc.’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$37.51 billion and a net profit of HK$2.73 billion. In comparison, last year the company earned a revenue of HK$29.82 billion and had a net profit of HK$2.12 billion
